![]() Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. | ![]() Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates. | ![]() Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. | |||
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2007 | Founding Date 2006 | Founding Date 2001 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Mateo, US HQ | Locations Lubbock, US HQ | Locations Bellaire, US HQ | Locations Houston, US HQ | Locations Norcross, US HQ |
Employees | Employees 1122% increase | Employees N/A | Employees 913% increase | Employees 176% decrease | Employees 717% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4 m | Valuation ($) 7.5 m | Valuation ($) 155.1 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($9.9m) (FY, 2024) | Net income ($33.6m) (FY, 2025) | Net income ($30.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 70m | Total funding raised $ 2.1m | Total funding raised $ 2.3m | Total funding raised $ 491k | Total funding raised N/A |

Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
View company
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
View company
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
View company